Evaxion A (EVAX) Capital Expenditures (2020 - 2022)
Evaxion A (EVAX) reported Capital Expenditures of -$83000.0 for Q2 2022, up 89.52% on a YoY basis from -$43794.8 in Q2 2021, and up 54.14% quarter-over-quarter from -$181000.0 in Q1 2022.
Evaxion A (EVAX) Capital Expenditures (2020 - 2022) Analysis & Trends
Evaxion A has reported Capital Expenditures for 3 years, with the latest figure at -$83000.0 in Q2 2022.
- For the quarter ending Q2 2022, Capital Expenditures rose 89.52% year-over-year to -$83000.0; the trailing twelve-month figure through Jun 2022 stood at -$2.2 million (down 78.1% YoY), and the FY2025 full-year result was $11000.0, changed N/A from the prior year.
- Capital Expenditures for Q2 2022 stood at -$83000.0, up from -$181000.0 in the prior quarter.
- The five-year high for Capital Expenditures was -$64000.0 in Q1 2020, with the low at -$1.1 million in Q3 2021.
- Historically, Capital Expenditures has averaged -$334500.0 across 3 years, with a median of -$132000.0 in 2022.
- Annual changes were most pronounced in 2021 — Capital Expenditures plunged 1378.95% — and 2022, when it jumped 89.52%.
- Evaxion A's Capital Expenditures stood at -$76000.0 in 2020, then sank by 1378.95% to -$1.1 million in 2021, then soared by 92.62% to -$83000.0 in 2022.
- The last three Capital Expenditures figures came in at -$83000.0 (Q2 2022), -$181000.0 (Q1 2022), and -$1.1 million (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 230.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -83,000.00 |
| Jun 30, 2022 | -83,000.00 |
| Mar 31, 2022 | -181,000.00 |
| Mar 31, 2022 | -181,000.00 |
| Sep 30, 2021 | -1.12 Mn |
| Sep 30, 2021 | -1.12 Mn |
| Jun 30, 2021 | -792,000.00 |
| Jun 30, 2021 | -792,000.00 |
| Mar 31, 2021 | -282,000.00 |
| Mar 31, 2021 | -282,000.00 |
| Sep 30, 2020 | -76,000.00 |
| Sep 30, 2020 | -76,000.00 |
| Jun 30, 2020 | -74,000.00 |
| Jun 30, 2020 | -74,000.00 |
| Mar 31, 2020 | -64,000.00 |
| Mar 31, 2020 | -64,000.00 |